Your browser doesn't support javascript.
loading
An exploratory study of sleep quality and quantity in children with causal variants in SYNGAP1, an autism risk gene.
Paasch, Valerie; Doucoure, Aida; Bifano, Morgan; Smith-Hicks, Constance L.
Afiliação
  • Paasch V; Department of Behavioral Psychology, Kennedy Krieger Institute Baltimore Maryland, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Doucoure A; Neurology and Developmental Medicine, Kennedy Krieger Institute Baltimore Maryland, USA.
  • Bifano M; Department of Behavioral Psychology, Kennedy Krieger Institute Baltimore Maryland, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Smith-Hicks CL; Neurology and Developmental Medicine, Kennedy Krieger Institute Baltimore Maryland, USA; Department of Neurology Johns Hopkins University School of Medicine, 707 N Broadway, 21205, Baltimore, MD, USA. Electronic address: hicksc@kennedykrieger.org.
Sleep Med ; 107: 101-107, 2023 07.
Article em En | MEDLINE | ID: mdl-37146502
STUDY OBJECTIVES: Sleep disturbances are reported in 62% of children with SYNGAP1-Intellectual Disability (SYNGAP1-ID), a rare neurodevelopmental disorder characterized by intellectual disability, epilepsy, autism spectrum disorder (ASD), sensory and behavioral challenges. Although Children's Sleep Habits Questionnaire (CSHQ) scores are elevated in children with SYNGAP1-ID factors that predict sleep disturbance are not well understood. The goal of this study is to identify predictors of sleep problems. METHODS: Parents of 21 children with SYNGAP1-ID completed questionnaires, and 6 children wore the Actiwatch2 for 14 continuous days. Non-parametric analysis of psychometric scales and actigraphy data were performed. Actigraphy derived sleep parameters were compared to controls and rest activity rhythms were assessed using arctools an open-source R package. RESULTS: CSHQ total sleep scores in children with SYNGAP1-ID and ASD were not different from children with SYNGAP1 without ASD (p = 0.61). Sleep anxiety (ß 1.646, 95% CI 0.9566 to 2.336) and parasomnias (ß 0.6294, 95% CI 0.06423 to 1.195) were strong predictors of bedtime resistance (R2 = 0.767, p < 0.001). The sedentary to active transition probability during the 12-18 h epoch (ß = 0.004, p = 0.008, R2 = 0.85) and the duration of the active bout during the 18-24 h epoch (ß = 0.166, p = 0.029, R2 = 0.74) were strong predictors of total sleep disturbance. CONCLUSION: The CSHQ may be a reliable measure of sleep difficulties in children with SYNGAP1-ID. Sleep anxiety, parasomnias and difficulty winding-down are significant contributors to sleep disturbances.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Autístico / Transtornos do Sono-Vigília / Parassonias / Transtorno do Espectro Autista / Deficiência Intelectual Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Autístico / Transtornos do Sono-Vigília / Parassonias / Transtorno do Espectro Autista / Deficiência Intelectual Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article